Insider Trades of SILVERSTEIN JONATHAN Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date ▲ Type Tran OwnerType Shares Traded Last Price Shares Held
INTERCEPT PHARMACEUTICALS INC Director 10/15/2013 Form 4 Sell indirect 376,585 62.5 1,775,022
INTERCEPT PHARMACEUTICALS INC Director 10/21/2013 Form 4 Sell indirect 40,088 62.5 1,734,934
RELYPSA INC Director 11/20/2013 Form 4 Acquisition (Non Open Market) indirect 7,511,930 0 7,511,930
RELYPSA INC Director 11/20/2013 Form 4 Disposition (Non Open Market) indirect 27,282 11 8,907,342
RELYPSA INC Director 11/20/2013 Form 4 Buy indirect 712,192 11 9,941,551
INTERCEPT PHARMACEUTICALS INC Director 04/09/2014 Form 4 Sell indirect 81,305 320 1,653,629
INTERCEPT PHARMACEUTICALS INC Director 07/17/2014 Form 4 Acquisition (Non Open Market) direct 285 0 285
ROKA BIOSCIENCE, INC. Director 07/22/2014 Form 4 Acquisition (Non Open Market) indirect 2,832,364 0 2,810,334
ROKA BIOSCIENCE, INC. Director 07/22/2014 Form 4 Buy indirect 383,333 12 3,220,429
INTERCEPT PHARMACEUTICALS INC Director 08/14/2014 Form 4 Sell indirect 60,000 292.701 1,596,582
INTERCEPT PHARMACEUTICALS INC Director 08/25/2014 Form 4 Sell indirect 50,000 294.67 1,546,582
INTERCEPT PHARMACEUTICALS INC Director 08/26/2014 Form 4 Sell indirect 61,258 299.13 1,485,324
INTERCEPT PHARMACEUTICALS INC Director 03/23/2015 Form 4 Sell indirect 159,400 270.7 1,325,924
INTERCEPT PHARMACEUTICALS INC Director 03/24/2015 Form 4 Sell indirect 45,600 268.13 1,280,324
INTERCEPT PHARMACEUTICALS INC Director 03/25/2015 Form 4 Sell indirect 2,800 270.23 1,277,524
INTERCEPT PHARMACEUTICALS INC Director 03/26/2015 Form 4 Sell indirect 157,200 281.11 1,120,324
GLAUKOS CORP Director 06/30/2015 Form 4 Acquisition (Non Open Market) indirect 2,882,064 0 2,854,870
GLAUKOS CORP Director 06/30/2015 Form 4 Disposition (Non Open Market) indirect 11,734 18 2,897,937

Create your free portfolio